{"title":"Neutrophils and NETs in kidney disease","authors":"Daigo Nakazawa, Sakiko Masuda, Yuka Nishibata, Kanako Watanabe-Kusunoki, Utano Tomaru, Akihiro Ishizu","doi":"10.1038/s41581-025-00944-3","DOIUrl":"10.1038/s41581-025-00944-3","url":null,"abstract":"Neutrophils, conventionally regarded as a homogeneous immune cell population, have emerged as a heterogeneous group of cells with distinct gene profiles and immune properties. Activated neutrophils release a spectrum of bioactive substances, including cytokines, chemokines, proteolytic enzymes, reactive oxygen species and neutrophil extracellular traps (NETs), which are composed of decondensed DNA and antimicrobial proteins. NETs have a pivotal role in innate immunity, including in preventing the ascent of uropathogenic bacteria into the kidneys, as they efficiently trap pathogenic microorganisms. However, although indispensable for defence against pathogens, NETs also pose risks of self-damage owing to their cytotoxicity, thrombogenicity and autoantigenicity. Accordingly, neutrophils and NETs have been implicated in the pathogenesis of various disorders that affect the kidneys, including acute kidney injury, vasculitis, systemic lupus erythematosus, thrombotic microangiopathy and in various aetiologies of chronic kidney disease. Pathological alterations in the glomerular vascular wall can promote the infiltration of neutrophils, which can cause tissue damage and inflammation through their interactions with kidney-resident cells, including mesangial cells and podocytes, leading to local cell death. Targeting neutrophil activation and NET formation might therefore represent a new therapeutic strategy for these conditions. Neutrophils and neutrophil extracellular traps are known for their key role in pathogen clearance. Here, the authors explore the dual role of neutrophils and neutrophil extracellular traps, as they can also have a pathogenic role in many kidney diseases through pro-inflammatory and pro-thrombotic effects, and by promoting autoimmunity.","PeriodicalId":19059,"journal":{"name":"Nature Reviews Nephrology","volume":"21 6","pages":"383-398"},"PeriodicalIF":39.8,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143653428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Unequal access: the prohibitive costs of new drugs in low- and middle-income countries","authors":"John M. Pettifor, Haroon Saloojee","doi":"10.1038/s41581-025-00948-z","DOIUrl":"10.1038/s41581-025-00948-z","url":null,"abstract":"The prohibitive costs of new pharmacological agents, particularly biologicals, have largely limited their use to high-income countries, resulting in widening of health disparities. Urgent action from the pharmaceutical industry, governments and healthcare organizations is needed to improve access to treatment and address these inequities.","PeriodicalId":19059,"journal":{"name":"Nature Reviews Nephrology","volume":"21 5","pages":"281-282"},"PeriodicalIF":39.8,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143627397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jonathan Haydak, Jacob Wright, Paula L. Croxson, Ilse S. Daehn
{"title":"Lived experience is essential for innovation in biomedical research","authors":"Jonathan Haydak, Jacob Wright, Paula L. Croxson, Ilse S. Daehn","doi":"10.1038/s41581-025-00940-7","DOIUrl":"10.1038/s41581-025-00940-7","url":null,"abstract":"The inclusion of individuals with disabilities and patients as partners in biomedical research is critical for driving innovation. Equally important are patient–researchers, who are instrumental in identifying key research problems and driving research towards areas of direct benefit. We call for institutions to actively work towards accommodating patient–researchers.","PeriodicalId":19059,"journal":{"name":"Nature Reviews Nephrology","volume":"21 6","pages":"362-363"},"PeriodicalIF":39.8,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143608309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A difficult path to point-of-care measurement of glomerular filtration rate","authors":"Pierre Delanaye, Richard J. Glassock","doi":"10.1038/s41581-025-00947-0","DOIUrl":"10.1038/s41581-025-00947-0","url":null,"abstract":"Transdermal detection of fluorescent markers has potential to provide point-of-care measurement of glomerular filtration rate. However, validation of proposed approaches and confirmation of their clinical utility should be required ahead of their adoption in the clinic.","PeriodicalId":19059,"journal":{"name":"Nature Reviews Nephrology","volume":"21 5","pages":"285-286"},"PeriodicalIF":39.8,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143598995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lilia Cervantes, Sri Lekha Tummalapalli, Delphine Tuot, Russell E. Glasgow
{"title":"The role of implementation science in advancing equity in kidney health","authors":"Lilia Cervantes, Sri Lekha Tummalapalli, Delphine Tuot, Russell E. Glasgow","doi":"10.1038/s41581-025-00949-y","DOIUrl":"10.1038/s41581-025-00949-y","url":null,"abstract":"Awareness of chronic kidney disease (CKD) and uptake of evidence-based interventions (EBIs) that increase awareness and/or slow progression to kidney failure remain alarmingly low. The global rise in immigration might exacerbate CKD prevalence among minoritized groups, which underscores the need for the nephrology community to acknowledge the diverse contexts that influence EBI implementation and to integrate health equity approaches.","PeriodicalId":19059,"journal":{"name":"Nature Reviews Nephrology","volume":"21 6","pages":"357-359"},"PeriodicalIF":39.8,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143589599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Reya H. Mokiao, Jason F. Deen, Amanda M. Fretts, Bessie A. Young
{"title":"Systemic interventions towards kidney health equity in American Indian and Alaska Native communities","authors":"Reya H. Mokiao, Jason F. Deen, Amanda M. Fretts, Bessie A. Young","doi":"10.1038/s41581-025-00943-4","DOIUrl":"10.1038/s41581-025-00943-4","url":null,"abstract":"Kidney disease disproportionately affects American Indian and Alaska Native (AI/AN) communities, largely owing to adverse social drivers of health that stem from systemic issues including colonization, structural racism and historical trauma. Kidney health equity for AI/AN communities requires systemic and multilevel interventions across the CKD spectrum and life course.","PeriodicalId":19059,"journal":{"name":"Nature Reviews Nephrology","volume":"21 6","pages":"360-361"},"PeriodicalIF":39.8,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143560789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Fiji’s rising tide: the growing burden of diabetic kidney disease on emerging nephrology services","authors":"Anis Ta’eed, Abhitesh Raj, Yogeshni Chandra, Shilpanjali Jesudason, Angus Ritchie","doi":"10.1038/s41581-025-00942-5","DOIUrl":"10.1038/s41581-025-00942-5","url":null,"abstract":"A growing burden of diabetic kidney disease in Fiji threatens to overwhelm newly established nephrology services. Greater attention to early detection and intervention, incorporation of kidney health into national strategic plans, and international support to prioritize chronic kidney disease as a global priority is imperative.","PeriodicalId":19059,"journal":{"name":"Nature Reviews Nephrology","volume":"21 5","pages":"279-280"},"PeriodicalIF":39.8,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143517973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cross-species evolution of capsid libraries for gene delivery to the kidneys","authors":"Monica Wang","doi":"10.1038/s41581-025-00945-2","DOIUrl":"10.1038/s41581-025-00945-2","url":null,"abstract":"","PeriodicalId":19059,"journal":{"name":"Nature Reviews Nephrology","volume":"21 4","pages":"217-217"},"PeriodicalIF":28.6,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143495198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jae Hyun Byun, Paul F. Lebeau, Jackie Trink, Nikhil Uppal, Matthew B. Lanktree, Joan C. Krepinsky, Richard C. Austin
{"title":"Endoplasmic reticulum stress as a driver and therapeutic target for kidney disease","authors":"Jae Hyun Byun, Paul F. Lebeau, Jackie Trink, Nikhil Uppal, Matthew B. Lanktree, Joan C. Krepinsky, Richard C. Austin","doi":"10.1038/s41581-025-00938-1","DOIUrl":"10.1038/s41581-025-00938-1","url":null,"abstract":"The endoplasmic reticulum (ER) has crucial roles in metabolically active cells, including protein translation, protein folding and quality control, lipid biosynthesis, and calcium homeostasis. Adverse metabolic conditions or pathogenic genetic variants that cause misfolding and accumulation of proteins within the ER of kidney cells initiate an injurious process known as ER stress that contributes to kidney disease and its cardiovascular complications. Initiation of ER stress activates the unfolded protein response (UPR), a cellular defence mechanism that functions to restore ER homeostasis. However, severe or chronic ER stress rewires the UPR to activate deleterious pathways that exacerbate inflammation, apoptosis and fibrosis, resulting in kidney injury. This insidious crosstalk between ER stress, UPR activation, oxidative stress and inflammation forms a vicious cycle that drives kidney disease and vascular damage. Furthermore, genetic variants that disrupt protein-folding mechanisms trigger ER stress, as evidenced in autosomal-dominant tubulointerstitial kidney disease and Fabry disease. Emerging therapeutic strategies that enhance protein-folding capacity and reduce the burden of ER stress have shown promising results in kidney diseases. Thus, integrating knowledge of how genetic variants cause protein misfolding and ER stress into clinical practice will enhance treatment strategies and potentially improve outcomes for various kidney diseases and their vascular complications. Endoplasmic reticulum (ER) stress is known to exacerbate chronic kidney disease and cardiovascular disease. Here, the authors discuss the role of ER stress in kidney disease and the link between ER stress, chronic kidney disease and cardiovascular disease.","PeriodicalId":19059,"journal":{"name":"Nature Reviews Nephrology","volume":"21 5","pages":"299-313"},"PeriodicalIF":39.8,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143477475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}